nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—Raloxifene—osteoporosis	0.0683	0.102	CbGbCtD
Modafinil—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0659	0.0981	CbGbCtD
Modafinil—CYP1A2—Estropipate—osteoporosis	0.06	0.0893	CbGbCtD
Modafinil—CYP2C9—Estropipate—osteoporosis	0.0541	0.0805	CbGbCtD
Modafinil—CYP2B6—Cholecalciferol—osteoporosis	0.0527	0.0785	CbGbCtD
Modafinil—CYP2C19—Cholecalciferol—osteoporosis	0.0335	0.0499	CbGbCtD
Modafinil—CYP3A5—Estradiol—osteoporosis	0.0335	0.0498	CbGbCtD
Modafinil—CYP3A4—Estropipate—osteoporosis	0.0314	0.0468	CbGbCtD
Modafinil—CYP3A4—Calcitriol—osteoporosis	0.0314	0.0468	CbGbCtD
Modafinil—CYP1A2—Conjugated Estrogens—osteoporosis	0.0284	0.0422	CbGbCtD
Modafinil—CYP2C9—Cholecalciferol—osteoporosis	0.0279	0.0414	CbGbCtD
Modafinil—CYP2C19—Estradiol—osteoporosis	0.027	0.0402	CbGbCtD
Modafinil—CYP3A4—Ergocalciferol—osteoporosis	0.0251	0.0374	CbGbCtD
Modafinil—CYP1A2—Estradiol—osteoporosis	0.0249	0.0371	CbGbCtD
Modafinil—CYP2C9—Estradiol—osteoporosis	0.0224	0.0334	CbGbCtD
Modafinil—CYP3A4—Raloxifene—osteoporosis	0.021	0.0312	CbGbCtD
Modafinil—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0203	0.0301	CbGbCtD
Modafinil—CYP3A4—Cholecalciferol—osteoporosis	0.0162	0.0241	CbGbCtD
Modafinil—CYP3A4—Conjugated Estrogens—osteoporosis	0.0149	0.0221	CbGbCtD
Modafinil—CYP3A4—Estradiol—osteoporosis	0.0131	0.0194	CbGbCtD
Modafinil—Bifonazole—CYP19A1—osteoporosis	0.000399	0.456	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP19A1—osteoporosis	0.0003	0.343	CrCbGaD
Modafinil—Erythema multiforme—Estradiol—osteoporosis	0.000202	0.000633	CcSEcCtD
Modafinil—Hypotension—Pamidronate—osteoporosis	0.000202	0.000632	CcSEcCtD
Modafinil—Convulsion—Conjugated Estrogens—osteoporosis	0.000202	0.000631	CcSEcCtD
Modafinil—Dry mouth—Zoledronate—osteoporosis	0.000201	0.00063	CcSEcCtD
Modafinil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000201	0.00063	CcSEcCtD
Modafinil—Fatigue—Ethinyl Estradiol—osteoporosis	0.000201	0.000629	CcSEcCtD
Modafinil—Pruritus—Alendronate—osteoporosis	0.0002	0.000627	CcSEcCtD
Modafinil—Dyspepsia—Risedronate—osteoporosis	0.0002	0.000626	CcSEcCtD
Modafinil—Constipation—Ethinyl Estradiol—osteoporosis	0.000199	0.000624	CcSEcCtD
Modafinil—Confusional state—Zoledronate—osteoporosis	0.000199	0.000623	CcSEcCtD
Modafinil—Hypersensitivity—Calcitriol—osteoporosis	0.000199	0.000622	CcSEcCtD
Modafinil—Cardiac disorder—Estradiol—osteoporosis	0.000199	0.000622	CcSEcCtD
Modafinil—Arthralgia—Conjugated Estrogens—osteoporosis	0.000198	0.00062	CcSEcCtD
Modafinil—Chest pain—Conjugated Estrogens—osteoporosis	0.000198	0.00062	CcSEcCtD
Modafinil—Myalgia—Conjugated Estrogens—osteoporosis	0.000198	0.00062	CcSEcCtD
Modafinil—Asthenia—Ibandronate—osteoporosis	0.000198	0.000619	CcSEcCtD
Modafinil—Anxiety—Conjugated Estrogens—osteoporosis	0.000197	0.000618	CcSEcCtD
Modafinil—Nausea—Etidronic acid—osteoporosis	0.000197	0.000618	CcSEcCtD
Modafinil—Oedema—Zoledronate—osteoporosis	0.000197	0.000618	CcSEcCtD
Modafinil—Anaphylactic shock—Zoledronate—osteoporosis	0.000197	0.000618	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000197	0.000616	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000197	0.000616	CcSEcCtD
Modafinil—Diarrhoea—Estropipate—osteoporosis	0.000197	0.000616	CcSEcCtD
Modafinil—Gastrointestinal disorder—Risedronate—osteoporosis	0.000196	0.000614	CcSEcCtD
Modafinil—Infection—Zoledronate—osteoporosis	0.000196	0.000613	CcSEcCtD
Modafinil—Fatigue—Risedronate—osteoporosis	0.000196	0.000613	CcSEcCtD
Modafinil—Insomnia—Pamidronate—osteoporosis	0.000195	0.000611	CcSEcCtD
Modafinil—Pruritus—Ibandronate—osteoporosis	0.000195	0.000611	CcSEcCtD
Modafinil—Pain—Risedronate—osteoporosis	0.000194	0.000608	CcSEcCtD
Modafinil—Constipation—Risedronate—osteoporosis	0.000194	0.000608	CcSEcCtD
Modafinil—Angiopathy—Estradiol—osteoporosis	0.000194	0.000608	CcSEcCtD
Modafinil—Shock—Zoledronate—osteoporosis	0.000194	0.000608	CcSEcCtD
Modafinil—Paraesthesia—Pamidronate—osteoporosis	0.000194	0.000607	CcSEcCtD
Modafinil—Diarrhoea—Alendronate—osteoporosis	0.000194	0.000606	CcSEcCtD
Modafinil—Asthenia—Calcitriol—osteoporosis	0.000194	0.000606	CcSEcCtD
Modafinil—Nervous system disorder—Zoledronate—osteoporosis	0.000193	0.000606	CcSEcCtD
Modafinil—Immune system disorder—Estradiol—osteoporosis	0.000193	0.000605	CcSEcCtD
Modafinil—Mediastinal disorder—Estradiol—osteoporosis	0.000193	0.000604	CcSEcCtD
Modafinil—Dyspnoea—Pamidronate—osteoporosis	0.000193	0.000603	CcSEcCtD
Modafinil—Tachycardia—Zoledronate—osteoporosis	0.000193	0.000603	CcSEcCtD
Modafinil—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000192	0.000601	CcSEcCtD
Modafinil—Chills—Estradiol—osteoporosis	0.000192	0.000601	CcSEcCtD
Modafinil—Somnolence—Pamidronate—osteoporosis	0.000192	0.000601	CcSEcCtD
Modafinil—Skin disorder—Zoledronate—osteoporosis	0.000192	0.0006	CcSEcCtD
Modafinil—Pruritus—Calcitriol—osteoporosis	0.000191	0.000598	CcSEcCtD
Modafinil—Hyperhidrosis—Zoledronate—osteoporosis	0.000191	0.000597	CcSEcCtD
Modafinil—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000191	0.000596	CcSEcCtD
Modafinil—Diarrhoea—Raloxifene—osteoporosis	0.000191	0.000596	CcSEcCtD
Modafinil—Dyspepsia—Pamidronate—osteoporosis	0.00019	0.000595	CcSEcCtD
Modafinil—Dizziness—Estropipate—osteoporosis	0.00019	0.000595	CcSEcCtD
Modafinil—Oedema—Conjugated Estrogens—osteoporosis	0.00019	0.000595	CcSEcCtD
Modafinil—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00019	0.000595	CcSEcCtD
Modafinil—Infection—Conjugated Estrogens—osteoporosis	0.000189	0.000591	CcSEcCtD
Modafinil—Diarrhoea—Ibandronate—osteoporosis	0.000189	0.00059	CcSEcCtD
Modafinil—Anorexia—Zoledronate—osteoporosis	0.000188	0.000589	CcSEcCtD
Modafinil—Decreased appetite—Pamidronate—osteoporosis	0.000188	0.000588	CcSEcCtD
Modafinil—Mental disorder—Estradiol—osteoporosis	0.000187	0.000587	CcSEcCtD
Modafinil—Dizziness—Alendronate—osteoporosis	0.000187	0.000586	CcSEcCtD
Modafinil—Shock—Conjugated Estrogens—osteoporosis	0.000187	0.000585	CcSEcCtD
Modafinil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000186	0.000584	CcSEcCtD
Modafinil—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000186	0.000583	CcSEcCtD
Modafinil—Malnutrition—Estradiol—osteoporosis	0.000186	0.000583	CcSEcCtD
Modafinil—Fatigue—Pamidronate—osteoporosis	0.000186	0.000583	CcSEcCtD
Modafinil—Gastrointestinal pain—Risedronate—osteoporosis	0.000186	0.000582	CcSEcCtD
Modafinil—Tachycardia—Conjugated Estrogens—osteoporosis	0.000185	0.00058	CcSEcCtD
Modafinil—Urticaria—Ethinyl Estradiol—osteoporosis	0.000185	0.000579	CcSEcCtD
Modafinil—Pain—Pamidronate—osteoporosis	0.000185	0.000578	CcSEcCtD
Modafinil—Constipation—Pamidronate—osteoporosis	0.000185	0.000578	CcSEcCtD
Modafinil—Diarrhoea—Calcitriol—osteoporosis	0.000185	0.000578	CcSEcCtD
Modafinil—Skin disorder—Conjugated Estrogens—osteoporosis	0.000185	0.000578	CcSEcCtD
Modafinil—Hypotension—Zoledronate—osteoporosis	0.000184	0.000577	CcSEcCtD
Modafinil—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000184	0.000577	CcSEcCtD
Modafinil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000184	0.000577	CcSEcCtD
Modafinil—Dizziness—Raloxifene—osteoporosis	0.000184	0.000576	CcSEcCtD
Modafinil—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000184	0.000575	CcSEcCtD
Modafinil—Flatulence—Estradiol—osteoporosis	0.000184	0.000575	CcSEcCtD
Modafinil—Tension—Estradiol—osteoporosis	0.000183	0.000572	CcSEcCtD
Modafinil—Vomiting—Estropipate—osteoporosis	0.000183	0.000572	CcSEcCtD
Modafinil—Dysgeusia—Estradiol—osteoporosis	0.000182	0.000571	CcSEcCtD
Modafinil—Dizziness—Ibandronate—osteoporosis	0.000182	0.000571	CcSEcCtD
Modafinil—Rash—Estropipate—osteoporosis	0.000181	0.000567	CcSEcCtD
Modafinil—Dermatitis—Estropipate—osteoporosis	0.000181	0.000567	CcSEcCtD
Modafinil—Anorexia—Conjugated Estrogens—osteoporosis	0.000181	0.000567	CcSEcCtD
Modafinil—Nervousness—Estradiol—osteoporosis	0.000181	0.000566	CcSEcCtD
Modafinil—Urticaria—Risedronate—osteoporosis	0.000181	0.000565	CcSEcCtD
Modafinil—Back pain—Estradiol—osteoporosis	0.00018	0.000564	CcSEcCtD
Modafinil—Headache—Estropipate—osteoporosis	0.00018	0.000564	CcSEcCtD
Modafinil—Vomiting—Alendronate—osteoporosis	0.00018	0.000564	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00018	0.000563	CcSEcCtD
Modafinil—Abdominal pain—Risedronate—osteoporosis	0.00018	0.000562	CcSEcCtD
Modafinil—Body temperature increased—Risedronate—osteoporosis	0.00018	0.000562	CcSEcCtD
Modafinil—Muscle spasms—Estradiol—osteoporosis	0.000179	0.000561	CcSEcCtD
Modafinil—Rash—Alendronate—osteoporosis	0.000179	0.000559	CcSEcCtD
Modafinil—Insomnia—Zoledronate—osteoporosis	0.000178	0.000559	CcSEcCtD
Modafinil—Dermatitis—Alendronate—osteoporosis	0.000178	0.000558	CcSEcCtD
Modafinil—Feeling abnormal—Pamidronate—osteoporosis	0.000178	0.000557	CcSEcCtD
Modafinil—Hypotension—Conjugated Estrogens—osteoporosis	0.000178	0.000556	CcSEcCtD
Modafinil—Headache—Alendronate—osteoporosis	0.000177	0.000555	CcSEcCtD
Modafinil—Paraesthesia—Zoledronate—osteoporosis	0.000177	0.000554	CcSEcCtD
Modafinil—Vomiting—Raloxifene—osteoporosis	0.000177	0.000554	CcSEcCtD
Modafinil—Gastrointestinal pain—Pamidronate—osteoporosis	0.000177	0.000553	CcSEcCtD
Modafinil—Methadone—CYP19A1—osteoporosis	0.000176	0.201	CrCbGaD
Modafinil—Dyspnoea—Zoledronate—osteoporosis	0.000176	0.000551	CcSEcCtD
Modafinil—Rash—Raloxifene—osteoporosis	0.000176	0.00055	CcSEcCtD
Modafinil—Dermatitis—Raloxifene—osteoporosis	0.000175	0.000549	CcSEcCtD
Modafinil—Somnolence—Zoledronate—osteoporosis	0.000175	0.000549	CcSEcCtD
Modafinil—Vomiting—Ibandronate—osteoporosis	0.000175	0.000549	CcSEcCtD
Modafinil—Tremor—Estradiol—osteoporosis	0.000175	0.000546	CcSEcCtD
Modafinil—Headache—Raloxifene—osteoporosis	0.000174	0.000546	CcSEcCtD
Modafinil—Rash—Ibandronate—osteoporosis	0.000174	0.000544	CcSEcCtD
Modafinil—Dermatitis—Ibandronate—osteoporosis	0.000174	0.000544	CcSEcCtD
Modafinil—Dyspepsia—Zoledronate—osteoporosis	0.000174	0.000544	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000173	0.000542	CcSEcCtD
Modafinil—Ill-defined disorder—Estradiol—osteoporosis	0.000173	0.000541	CcSEcCtD
Modafinil—Headache—Ibandronate—osteoporosis	0.000173	0.000541	CcSEcCtD
Modafinil—Insomnia—Conjugated Estrogens—osteoporosis	0.000172	0.000538	CcSEcCtD
Modafinil—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000172	0.000537	CcSEcCtD
Modafinil—Vomiting—Calcitriol—osteoporosis	0.000172	0.000537	CcSEcCtD
Modafinil—Decreased appetite—Zoledronate—osteoporosis	0.000172	0.000537	CcSEcCtD
Modafinil—Agitation—Estradiol—osteoporosis	0.000171	0.000536	CcSEcCtD
Modafinil—Nausea—Estropipate—osteoporosis	0.000171	0.000535	CcSEcCtD
Modafinil—Body temperature increased—Pamidronate—osteoporosis	0.000171	0.000534	CcSEcCtD
Modafinil—Abdominal pain—Pamidronate—osteoporosis	0.000171	0.000534	CcSEcCtD
Modafinil—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000171	0.000534	CcSEcCtD
Modafinil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00017	0.000533	CcSEcCtD
Modafinil—Angioedema—Estradiol—osteoporosis	0.00017	0.000533	CcSEcCtD
Modafinil—Rash—Calcitriol—osteoporosis	0.00017	0.000533	CcSEcCtD
Modafinil—Fatigue—Zoledronate—osteoporosis	0.00017	0.000532	CcSEcCtD
Modafinil—Dermatitis—Calcitriol—osteoporosis	0.00017	0.000532	CcSEcCtD
Modafinil—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000169	0.00053	CcSEcCtD
Modafinil—Headache—Calcitriol—osteoporosis	0.000169	0.000529	CcSEcCtD
Modafinil—Somnolence—Conjugated Estrogens—osteoporosis	0.000169	0.000529	CcSEcCtD
Modafinil—Constipation—Zoledronate—osteoporosis	0.000169	0.000528	CcSEcCtD
Modafinil—Pain—Zoledronate—osteoporosis	0.000169	0.000528	CcSEcCtD
Modafinil—Nausea—Alendronate—osteoporosis	0.000168	0.000526	CcSEcCtD
Modafinil—Malaise—Estradiol—osteoporosis	0.000168	0.000526	CcSEcCtD
Modafinil—Hypersensitivity—Risedronate—osteoporosis	0.000167	0.000524	CcSEcCtD
Modafinil—Vertigo—Estradiol—osteoporosis	0.000167	0.000524	CcSEcCtD
Modafinil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000167	0.000523	CcSEcCtD
Modafinil—Asthenia—Ethinyl Estradiol—osteoporosis	0.000167	0.000523	CcSEcCtD
Modafinil—Syncope—Estradiol—osteoporosis	0.000167	0.000523	CcSEcCtD
Modafinil—Nausea—Raloxifene—osteoporosis	0.000165	0.000518	CcSEcCtD
Modafinil—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000165	0.000517	CcSEcCtD
Modafinil—Pruritus—Ethinyl Estradiol—osteoporosis	0.000165	0.000516	CcSEcCtD
Modafinil—Palpitations—Estradiol—osteoporosis	0.000165	0.000515	CcSEcCtD
Modafinil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000164	0.000513	CcSEcCtD
Modafinil—Fatigue—Conjugated Estrogens—osteoporosis	0.000164	0.000513	CcSEcCtD
Modafinil—Nausea—Ibandronate—osteoporosis	0.000164	0.000513	CcSEcCtD
Modafinil—Loss of consciousness—Estradiol—osteoporosis	0.000164	0.000512	CcSEcCtD
Modafinil—Asthenia—Risedronate—osteoporosis	0.000163	0.00051	CcSEcCtD
Modafinil—Feeling abnormal—Zoledronate—osteoporosis	0.000163	0.000509	CcSEcCtD
Modafinil—Cough—Estradiol—osteoporosis	0.000163	0.000509	CcSEcCtD
Modafinil—Constipation—Conjugated Estrogens—osteoporosis	0.000162	0.000508	CcSEcCtD
Modafinil—Pain—Conjugated Estrogens—osteoporosis	0.000162	0.000508	CcSEcCtD
Modafinil—Gastrointestinal pain—Zoledronate—osteoporosis	0.000161	0.000505	CcSEcCtD
Modafinil—Hypertension—Estradiol—osteoporosis	0.000161	0.000503	CcSEcCtD
Modafinil—Pruritus—Risedronate—osteoporosis	0.000161	0.000503	CcSEcCtD
Modafinil—Nausea—Calcitriol—osteoporosis	0.00016	0.000502	CcSEcCtD
Modafinil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000159	0.000499	CcSEcCtD
Modafinil—Hypersensitivity—Pamidronate—osteoporosis	0.000159	0.000498	CcSEcCtD
Modafinil—Arthralgia—Estradiol—osteoporosis	0.000159	0.000496	CcSEcCtD
Modafinil—Chest pain—Estradiol—osteoporosis	0.000159	0.000496	CcSEcCtD
Modafinil—Myalgia—Estradiol—osteoporosis	0.000159	0.000496	CcSEcCtD
Modafinil—Anxiety—Estradiol—osteoporosis	0.000158	0.000495	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000158	0.000493	CcSEcCtD
Modafinil—Urticaria—Zoledronate—osteoporosis	0.000157	0.000491	CcSEcCtD
Modafinil—Discomfort—Estradiol—osteoporosis	0.000157	0.00049	CcSEcCtD
Modafinil—Body temperature increased—Zoledronate—osteoporosis	0.000156	0.000488	CcSEcCtD
Modafinil—Abdominal pain—Zoledronate—osteoporosis	0.000156	0.000488	CcSEcCtD
Modafinil—Diarrhoea—Risedronate—osteoporosis	0.000155	0.000487	CcSEcCtD
Modafinil—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000155	0.000486	CcSEcCtD
Modafinil—Dry mouth—Estradiol—osteoporosis	0.000155	0.000485	CcSEcCtD
Modafinil—Asthenia—Pamidronate—osteoporosis	0.000155	0.000485	CcSEcCtD
Modafinil—Dizziness—Ethinyl Estradiol—osteoporosis	0.000154	0.000482	CcSEcCtD
Modafinil—Confusional state—Estradiol—osteoporosis	0.000153	0.00048	CcSEcCtD
Modafinil—Pruritus—Pamidronate—osteoporosis	0.000153	0.000478	CcSEcCtD
Modafinil—Anaphylactic shock—Estradiol—osteoporosis	0.000152	0.000476	CcSEcCtD
Modafinil—Oedema—Estradiol—osteoporosis	0.000152	0.000476	CcSEcCtD
Modafinil—Infection—Estradiol—osteoporosis	0.000151	0.000473	CcSEcCtD
Modafinil—Urticaria—Conjugated Estrogens—osteoporosis	0.000151	0.000472	CcSEcCtD
Modafinil—Dizziness—Risedronate—osteoporosis	0.00015	0.00047	CcSEcCtD
Modafinil—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00015	0.00047	CcSEcCtD
Modafinil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00015	0.00047	CcSEcCtD
Modafinil—Shock—Estradiol—osteoporosis	0.00015	0.000468	CcSEcCtD
Modafinil—Nervous system disorder—Estradiol—osteoporosis	0.000149	0.000467	CcSEcCtD
Modafinil—Tachycardia—Estradiol—osteoporosis	0.000148	0.000464	CcSEcCtD
Modafinil—Vomiting—Ethinyl Estradiol—osteoporosis	0.000148	0.000464	CcSEcCtD
Modafinil—Diarrhoea—Pamidronate—osteoporosis	0.000148	0.000463	CcSEcCtD
Modafinil—Skin disorder—Estradiol—osteoporosis	0.000148	0.000462	CcSEcCtD
Modafinil—Hyperhidrosis—Estradiol—osteoporosis	0.000147	0.00046	CcSEcCtD
Modafinil—Rash—Ethinyl Estradiol—osteoporosis	0.000147	0.00046	CcSEcCtD
Modafinil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000147	0.000459	CcSEcCtD
Modafinil—Headache—Ethinyl Estradiol—osteoporosis	0.000146	0.000457	CcSEcCtD
Modafinil—Hypersensitivity—Zoledronate—osteoporosis	0.000145	0.000455	CcSEcCtD
Modafinil—Vomiting—Risedronate—osteoporosis	0.000144	0.000452	CcSEcCtD
Modafinil—Rash—Risedronate—osteoporosis	0.000143	0.000448	CcSEcCtD
Modafinil—Dermatitis—Risedronate—osteoporosis	0.000143	0.000448	CcSEcCtD
Modafinil—Dizziness—Pamidronate—osteoporosis	0.000143	0.000447	CcSEcCtD
Modafinil—Headache—Risedronate—osteoporosis	0.000142	0.000446	CcSEcCtD
Modafinil—Asthenia—Zoledronate—osteoporosis	0.000142	0.000443	CcSEcCtD
Modafinil—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00014	0.000438	CcSEcCtD
Modafinil—Pruritus—Zoledronate—osteoporosis	0.00014	0.000437	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000139	0.000434	CcSEcCtD
Modafinil—Nausea—Ethinyl Estradiol—osteoporosis	0.000138	0.000433	CcSEcCtD
Modafinil—Insomnia—Estradiol—osteoporosis	0.000138	0.00043	CcSEcCtD
Modafinil—Vomiting—Pamidronate—osteoporosis	0.000137	0.00043	CcSEcCtD
Modafinil—Paraesthesia—Estradiol—osteoporosis	0.000137	0.000427	CcSEcCtD
Modafinil—Asthenia—Conjugated Estrogens—osteoporosis	0.000136	0.000427	CcSEcCtD
Modafinil—Rash—Pamidronate—osteoporosis	0.000136	0.000426	CcSEcCtD
Modafinil—Dermatitis—Pamidronate—osteoporosis	0.000136	0.000426	CcSEcCtD
Modafinil—Dyspnoea—Estradiol—osteoporosis	0.000136	0.000424	CcSEcCtD
Modafinil—Headache—Pamidronate—osteoporosis	0.000135	0.000424	CcSEcCtD
Modafinil—Somnolence—Estradiol—osteoporosis	0.000135	0.000423	CcSEcCtD
Modafinil—Diarrhoea—Zoledronate—osteoporosis	0.000135	0.000423	CcSEcCtD
Modafinil—Nausea—Risedronate—osteoporosis	0.000135	0.000422	CcSEcCtD
Modafinil—Pruritus—Conjugated Estrogens—osteoporosis	0.000134	0.000421	CcSEcCtD
Modafinil—Dyspepsia—Estradiol—osteoporosis	0.000134	0.000419	CcSEcCtD
Modafinil—Decreased appetite—Estradiol—osteoporosis	0.000132	0.000414	CcSEcCtD
Modafinil—Gastrointestinal disorder—Estradiol—osteoporosis	0.000131	0.000411	CcSEcCtD
Modafinil—Fatigue—Estradiol—osteoporosis	0.000131	0.00041	CcSEcCtD
Modafinil—Dizziness—Zoledronate—osteoporosis	0.00013	0.000408	CcSEcCtD
Modafinil—Pain—Estradiol—osteoporosis	0.00013	0.000407	CcSEcCtD
Modafinil—Constipation—Estradiol—osteoporosis	0.00013	0.000407	CcSEcCtD
Modafinil—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00013	0.000407	CcSEcCtD
Modafinil—Nausea—Pamidronate—osteoporosis	0.000128	0.000402	CcSEcCtD
Modafinil—Dizziness—Conjugated Estrogens—osteoporosis	0.000126	0.000393	CcSEcCtD
Modafinil—Vomiting—Zoledronate—osteoporosis	0.000125	0.000393	CcSEcCtD
Modafinil—Feeling abnormal—Estradiol—osteoporosis	0.000125	0.000392	CcSEcCtD
Modafinil—Rash—Zoledronate—osteoporosis	0.000124	0.000389	CcSEcCtD
Modafinil—Gastrointestinal pain—Estradiol—osteoporosis	0.000124	0.000389	CcSEcCtD
Modafinil—Dermatitis—Zoledronate—osteoporosis	0.000124	0.000389	CcSEcCtD
Modafinil—Headache—Zoledronate—osteoporosis	0.000124	0.000387	CcSEcCtD
Modafinil—Vomiting—Conjugated Estrogens—osteoporosis	0.000121	0.000378	CcSEcCtD
Modafinil—Urticaria—Estradiol—osteoporosis	0.000121	0.000378	CcSEcCtD
Modafinil—Abdominal pain—Estradiol—osteoporosis	0.00012	0.000376	CcSEcCtD
Modafinil—Body temperature increased—Estradiol—osteoporosis	0.00012	0.000376	CcSEcCtD
Modafinil—Rash—Conjugated Estrogens—osteoporosis	0.00012	0.000375	CcSEcCtD
Modafinil—Dermatitis—Conjugated Estrogens—osteoporosis	0.00012	0.000375	CcSEcCtD
Modafinil—Headache—Conjugated Estrogens—osteoporosis	0.000119	0.000372	CcSEcCtD
Modafinil—Nausea—Zoledronate—osteoporosis	0.000117	0.000367	CcSEcCtD
Modafinil—Nausea—Conjugated Estrogens—osteoporosis	0.000113	0.000353	CcSEcCtD
Modafinil—Hypersensitivity—Estradiol—osteoporosis	0.000112	0.000351	CcSEcCtD
Modafinil—Asthenia—Estradiol—osteoporosis	0.000109	0.000341	CcSEcCtD
Modafinil—Pruritus—Estradiol—osteoporosis	0.000108	0.000337	CcSEcCtD
Modafinil—Diarrhoea—Estradiol—osteoporosis	0.000104	0.000326	CcSEcCtD
Modafinil—Dizziness—Estradiol—osteoporosis	0.000101	0.000315	CcSEcCtD
Modafinil—Vomiting—Estradiol—osteoporosis	9.67e-05	0.000303	CcSEcCtD
Modafinil—Rash—Estradiol—osteoporosis	9.59e-05	0.0003	CcSEcCtD
Modafinil—Dermatitis—Estradiol—osteoporosis	9.58e-05	0.0003	CcSEcCtD
Modafinil—Headache—Estradiol—osteoporosis	9.53e-05	0.000298	CcSEcCtD
Modafinil—Nausea—Estradiol—osteoporosis	9.03e-05	0.000283	CcSEcCtD
Modafinil—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.99e-05	0.00259	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—MGLL—osteoporosis	1.99e-05	0.00259	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—PTHLH—osteoporosis	1.93e-05	0.00251	CbGpPWpGaD
Modafinil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.89e-05	0.00246	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	1.83e-05	0.00238	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	1.83e-05	0.00238	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	1.81e-05	0.00236	CbGpPWpGaD
Modafinil—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	1.8e-05	0.00235	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—MGLL—osteoporosis	1.8e-05	0.00235	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.72e-05	0.00224	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.72e-05	0.00224	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—CALCA—osteoporosis	1.7e-05	0.00221	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.67e-05	0.00218	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	1.67e-05	0.00217	CbGpPWpGaD
Modafinil—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	1.65e-05	0.00214	CbGpPWpGaD
Modafinil—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.61e-05	0.0021	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.57e-05	0.00204	CbGpPWpGaD
Modafinil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.54e-05	0.002	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.53e-05	0.002	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.53e-05	0.00199	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SOST—osteoporosis	1.48e-05	0.00193	CbGpPWpGaD
Modafinil—CYP2B6—Biological oxidations—POMC—osteoporosis	1.46e-05	0.0019	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	1.43e-05	0.00186	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.42e-05	0.00185	CbGpPWpGaD
Modafinil—CYP3A5—Biological oxidations—POMC—osteoporosis	1.42e-05	0.00185	CbGpPWpGaD
Modafinil—SLC6A3—NRF2 pathway—TGFB1—osteoporosis	1.42e-05	0.00185	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	1.42e-05	0.00185	CbGpPWpGaD
Modafinil—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	1.41e-05	0.00183	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—FDPS—osteoporosis	1.37e-05	0.00179	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PKM—osteoporosis	1.37e-05	0.00179	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—FDPS—osteoporosis	1.34e-05	0.00175	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PKM—osteoporosis	1.34e-05	0.00175	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CALCR—osteoporosis	1.34e-05	0.00175	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTH1R—osteoporosis	1.34e-05	0.00175	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.34e-05	0.00174	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.34e-05	0.00174	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	1.33e-05	0.00173	CbGpPWpGaD
Modafinil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.33e-05	0.00173	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PTH—osteoporosis	1.31e-05	0.00171	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.3e-05	0.0017	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PGLS—osteoporosis	1.3e-05	0.0017	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPD2—osteoporosis	1.3e-05	0.0017	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CNR2—osteoporosis	1.28e-05	0.00167	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PGLS—osteoporosis	1.27e-05	0.00166	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPD2—osteoporosis	1.27e-05	0.00166	CbGpPWpGaD
Modafinil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.25e-05	0.00162	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.22e-05	0.00159	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PTH—osteoporosis	1.19e-05	0.00155	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ATIC—osteoporosis	1.19e-05	0.00155	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PNP—osteoporosis	1.19e-05	0.00155	CbGpPWpGaD
Modafinil—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.17e-05	0.00152	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ATIC—osteoporosis	1.16e-05	0.00152	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PNP—osteoporosis	1.16e-05	0.00152	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CNR2—osteoporosis	1.16e-05	0.00151	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.14e-05	0.00148	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.1e-05	0.00143	CbGpPWpGaD
Modafinil—CYP2C19—Biological oxidations—POMC—osteoporosis	1.1e-05	0.00143	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—WNT1—osteoporosis	1.09e-05	0.00142	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PTHLH—osteoporosis	1.09e-05	0.00142	CbGpPWpGaD
Modafinil—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.09e-05	0.00141	CbGpPWpGaD
Modafinil—SLC6A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.07e-05	0.0014	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MGLL—osteoporosis	1.07e-05	0.00139	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.04e-05	0.00136	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LRP5—osteoporosis	1.04e-05	0.00136	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PKM—osteoporosis	1.04e-05	0.00135	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—FDPS—osteoporosis	1.04e-05	0.00135	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.04e-05	0.00135	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CA2—osteoporosis	1.01e-05	0.00132	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—OXCT1—osteoporosis	1.01e-05	0.00132	CbGpPWpGaD
Modafinil—CYP2C9—Biological oxidations—POMC—osteoporosis	1e-05	0.00131	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LRP6—osteoporosis	9.95e-06	0.0013	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—OXCT1—osteoporosis	9.89e-06	0.00129	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CA2—osteoporosis	9.89e-06	0.00129	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PTHLH—osteoporosis	9.89e-06	0.00129	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MGLL—osteoporosis	9.86e-06	0.00129	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PGLS—osteoporosis	9.83e-06	0.00128	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPD2—osteoporosis	9.83e-06	0.00128	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MGLL—osteoporosis	9.64e-06	0.00126	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—CALCA—osteoporosis	9.58e-06	0.00125	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PKM—osteoporosis	9.46e-06	0.00123	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—FDPS—osteoporosis	9.46e-06	0.00123	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PNP—osteoporosis	8.99e-06	0.00117	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ATIC—osteoporosis	8.99e-06	0.00117	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPD2—osteoporosis	8.97e-06	0.00117	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PGLS—osteoporosis	8.97e-06	0.00117	CbGpPWpGaD
Modafinil—ADRA1B—GPCR ligand binding—POMC—osteoporosis	8.87e-06	0.00116	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	8.86e-06	0.00115	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—CALCA—osteoporosis	8.7e-06	0.00113	CbGpPWpGaD
Modafinil—CYP1A2—Biological oxidations—POMC—osteoporosis	8.57e-06	0.00112	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TLN1—osteoporosis	8.4e-06	0.00109	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—IDH2—osteoporosis	8.39e-06	0.00109	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PNP—osteoporosis	8.2e-06	0.00107	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ATIC—osteoporosis	8.2e-06	0.00107	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—IDH2—osteoporosis	8.2e-06	0.00107	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PKM—osteoporosis	8.08e-06	0.00105	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—FDPS—osteoporosis	8.08e-06	0.00105	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP27A1—osteoporosis	7.88e-06	0.00103	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP27A1—osteoporosis	7.71e-06	0.001	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ACP5—osteoporosis	7.67e-06	0.000999	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PGLS—osteoporosis	7.66e-06	0.000998	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPD2—osteoporosis	7.66e-06	0.000998	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CA2—osteoporosis	7.65e-06	0.000997	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—OXCT1—osteoporosis	7.65e-06	0.000997	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ACP5—osteoporosis	7.5e-06	0.000977	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MGLL—osteoporosis	7.45e-06	0.000971	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—P4HB—osteoporosis	7.24e-06	0.000944	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—TPI1—osteoporosis	7.13e-06	0.000929	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTH—osteoporosis	7.05e-06	0.000918	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.03e-06	0.000916	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ATIC—osteoporosis	7.01e-06	0.000913	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PNP—osteoporosis	7.01e-06	0.000913	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CA2—osteoporosis	6.97e-06	0.000909	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—OXCT1—osteoporosis	6.97e-06	0.000909	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—TPI1—osteoporosis	6.97e-06	0.000908	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—RAP1A—osteoporosis	6.93e-06	0.000902	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CNR2—osteoporosis	6.87e-06	0.000895	CbGpPWpGaD
Modafinil—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	6.84e-06	0.000891	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—ADCY5—osteoporosis	6.82e-06	0.000888	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MGLL—osteoporosis	6.8e-06	0.000885	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NFATC1—osteoporosis	6.76e-06	0.00088	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—P4HB—osteoporosis	6.7e-06	0.000874	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—DKK1—osteoporosis	6.7e-06	0.000873	CbGpPWpGaD
Modafinil—CYP3A4—Biological oxidations—POMC—osteoporosis	6.61e-06	0.000862	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GAPDH—osteoporosis	6.58e-06	0.000857	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—P4HB—osteoporosis	6.55e-06	0.000854	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—WNT1—osteoporosis	6.46e-06	0.000841	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GAPDH—osteoporosis	6.43e-06	0.000838	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—RAP1A—osteoporosis	6.41e-06	0.000835	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.41e-06	0.000835	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—IDH2—osteoporosis	6.34e-06	0.000826	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGA—osteoporosis	6.28e-06	0.000819	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—RAP1A—osteoporosis	6.26e-06	0.000816	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—FDPS—osteoporosis	6.24e-06	0.000813	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PKM—osteoporosis	6.24e-06	0.000813	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	6.19e-06	0.000807	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—OXCT1—osteoporosis	5.96e-06	0.000776	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CA2—osteoporosis	5.96e-06	0.000776	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP27A1—osteoporosis	5.96e-06	0.000776	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PGLS—osteoporosis	5.91e-06	0.000771	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPD2—osteoporosis	5.91e-06	0.000771	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	5.84e-06	0.000761	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BMP2—osteoporosis	5.84e-06	0.000761	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MGLL—osteoporosis	5.81e-06	0.000757	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ACP5—osteoporosis	5.8e-06	0.000755	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—IDH2—osteoporosis	5.78e-06	0.000753	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.72e-06	0.000746	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGB—osteoporosis	5.71e-06	0.000745	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	5.52e-06	0.000719	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	5.52e-06	0.000719	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.48e-06	0.000714	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP27A1—osteoporosis	5.43e-06	0.000708	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ATIC—osteoporosis	5.41e-06	0.000705	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PNP—osteoporosis	5.41e-06	0.000705	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TPI1—osteoporosis	5.39e-06	0.000702	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ACP5—osteoporosis	5.28e-06	0.000689	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.22e-06	0.00068	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ENO1—osteoporosis	5.18e-06	0.000675	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CALCA—osteoporosis	5.14e-06	0.00067	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PSMA2—osteoporosis	5.1e-06	0.000665	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PSMA5—osteoporosis	5.1e-06	0.000665	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—P4HB—osteoporosis	5.07e-06	0.00066	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ENO1—osteoporosis	5.06e-06	0.00066	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	5.01e-06	0.000653	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PSMA5—osteoporosis	4.99e-06	0.00065	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PSMA2—osteoporosis	4.99e-06	0.00065	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GAPDH—osteoporosis	4.97e-06	0.000648	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—IDH2—osteoporosis	4.94e-06	0.000643	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TPI1—osteoporosis	4.91e-06	0.00064	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—RAP1A—osteoporosis	4.84e-06	0.000631	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KL—osteoporosis	4.67e-06	0.000608	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP27A1—osteoporosis	4.64e-06	0.000605	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—P4HB—osteoporosis	4.62e-06	0.000602	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—OXCT1—osteoporosis	4.6e-06	0.000599	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CA2—osteoporosis	4.6e-06	0.000599	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—POMC—osteoporosis	4.55e-06	0.000593	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GAPDH—osteoporosis	4.53e-06	0.000591	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ACP5—osteoporosis	4.52e-06	0.000588	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MGLL—osteoporosis	4.48e-06	0.000584	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.46e-06	0.000581	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	4.44e-06	0.000579	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—RAP1A—osteoporosis	4.42e-06	0.000575	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.22e-06	0.00055	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TPI1—osteoporosis	4.2e-06	0.000547	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CYP19A1—osteoporosis	4.14e-06	0.00054	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP19A1—osteoporosis	4.05e-06	0.000528	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—P4HB—osteoporosis	3.95e-06	0.000514	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ENO1—osteoporosis	3.91e-06	0.00051	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GAPDH—osteoporosis	3.87e-06	0.000505	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PSMA2—osteoporosis	3.86e-06	0.000503	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PSMA5—osteoporosis	3.86e-06	0.000503	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.85e-06	0.000502	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—IDH2—osteoporosis	3.81e-06	0.000497	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—RAP1A—osteoporosis	3.77e-06	0.000492	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	3.66e-06	0.000477	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.58e-06	0.000467	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ENO1—osteoporosis	3.57e-06	0.000465	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SPP1—osteoporosis	3.54e-06	0.000461	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSMA2—osteoporosis	3.52e-06	0.000458	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PSMA5—osteoporosis	3.52e-06	0.000458	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ACP5—osteoporosis	3.49e-06	0.000454	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ADCY5—osteoporosis	3.38e-06	0.000441	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—GPX1—osteoporosis	3.37e-06	0.000439	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ADCY5—osteoporosis	3.31e-06	0.000431	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—GPX1—osteoporosis	3.3e-06	0.00043	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.29e-06	0.000429	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TPI1—osteoporosis	3.24e-06	0.000422	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS2—osteoporosis	3.2e-06	0.000417	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—osteoporosis	3.13e-06	0.000408	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP19A1—osteoporosis	3.13e-06	0.000408	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—osteoporosis	3.11e-06	0.000406	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ENO1—osteoporosis	3.05e-06	0.000397	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—P4HB—osteoporosis	3.05e-06	0.000397	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—osteoporosis	3.04e-06	0.000396	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSMA2—osteoporosis	3.01e-06	0.000392	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PSMA5—osteoporosis	3.01e-06	0.000392	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GAPDH—osteoporosis	2.99e-06	0.00039	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ESR1—osteoporosis	2.99e-06	0.00039	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—RAP1A—osteoporosis	2.91e-06	0.000379	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP19A1—osteoporosis	2.85e-06	0.000372	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS1—osteoporosis	2.79e-06	0.000364	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—POMC—osteoporosis	2.69e-06	0.000351	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6R—osteoporosis	2.62e-06	0.000342	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—osteoporosis	2.59e-06	0.000337	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ADCY5—osteoporosis	2.56e-06	0.000333	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GPX1—osteoporosis	2.55e-06	0.000332	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—POMC—osteoporosis	2.49e-06	0.000324	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.44e-06	0.000318	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—POMC—osteoporosis	2.43e-06	0.000317	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ENO1—osteoporosis	2.35e-06	0.000307	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—osteoporosis	2.35e-06	0.000306	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ADCY5—osteoporosis	2.33e-06	0.000304	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GPX1—osteoporosis	2.32e-06	0.000303	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSMA2—osteoporosis	2.32e-06	0.000302	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PSMA5—osteoporosis	2.32e-06	0.000302	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—osteoporosis	2.14e-06	0.000279	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ADCY5—osteoporosis	1.99e-06	0.00026	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GPX1—osteoporosis	1.99e-06	0.000259	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.98e-06	0.000258	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.88e-06	0.000245	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—POMC—osteoporosis	1.88e-06	0.000245	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—osteoporosis	1.83e-06	0.000239	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—POMC—osteoporosis	1.71e-06	0.000223	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—osteoporosis	1.55e-06	0.000203	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	1.55e-06	0.000202	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ADCY5—osteoporosis	1.54e-06	0.0002	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GPX1—osteoporosis	1.53e-06	0.0002	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—POMC—osteoporosis	1.47e-06	0.000191	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—osteoporosis	1.41e-06	0.000184	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—osteoporosis	1.17e-06	0.000152	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—POMC—osteoporosis	1.13e-06	0.000147	CbGpPWpGaD
